2008
DOI: 10.1016/j.tetlet.2007.11.104
|View full text |Cite
|
Sign up to set email alerts
|

The first approach to optically active 2,2′-bipyridine alkyl sulfoxides

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2009
2009
2017
2017

Publication Types

Select...
4
2

Relationship

2
4

Authors

Journals

citations
Cited by 15 publications
(9 citation statements)
references
References 30 publications
0
9
0
Order By: Relevance
“…[14] In this work, we report a new approach to 1:1 thiacrown ether macrocycles and their sulfoxides incorporating a cyclopenteno[c]2,2Ј-bipyridine subunit, as well as X-ray crystallographic analysis of the target ligands. Our preliminary findings [15] and these studies suggest that this approach is fairly general for the preparation of large-sized rings, that is, rings having 13-22 or more atoms.…”
Section: Introductionmentioning
confidence: 52%
See 3 more Smart Citations
“…[14] In this work, we report a new approach to 1:1 thiacrown ether macrocycles and their sulfoxides incorporating a cyclopenteno[c]2,2Ј-bipyridine subunit, as well as X-ray crystallographic analysis of the target ligands. Our preliminary findings [15] and these studies suggest that this approach is fairly general for the preparation of large-sized rings, that is, rings having 13-22 or more atoms.…”
Section: Introductionmentioning
confidence: 52%
“…N1A-C2A-C2B-N1B 0.4(2) -31.9 N1B-C6B-S10B-C11B -1.66 (17) 7.3 N1A-C6A-S10A-C11A -8.5(6) 2.5 C6B-S10B-C11B-C12B 174.06 (15) 98.6 C6A-S10A-C11A-C12A -141.7(9) -148.6 S10B-C11B-C12B-O13B -179.69(13) -178.8 S10A-C11A-C12A-O13A -54.0(12)…”
Section: Torsion Angle [°]mentioning
confidence: 99%
See 2 more Smart Citations
“…This is based on the fact that the reported enantiomeric excess values differ very much for derivatives having very similar structures. Among them there are papers co-authored by one of us [99][100] devoted to the asymmetric oxidation of 2,2'-bipyridine alkyl sulfides 15a-e to non-racemic 2,2'-bipyridine alkyl sulfoxides 16a-e and bis-sulfoxides 17a-e using either (+)- (8,8-dichlorocamphorylsulfonyl) oxaziridine (method A) 101 or the Kagan reagent (method B) 91 (Scheme 9). Scheme 9.…”
Section: Comments Related To Problems With the Accurate Determinationmentioning
confidence: 99%